Plazomicin's BSI Indication Gets 'No' From Advisory Panel, But US FDA Still Might Approve Under LPAD Pathway

 
• By Michael Cipriano
Lily pad
Which of the proposed indications for Achaogen's plazomicin will flower?

More from US FDA Performance Tracker

More from Regulatory Trackers